Rafferty Asset Management
VNDA icon

Rafferty Asset Management’s Vanda Pharmaceuticals VNDA Stock Holding History

Rafferty Asset Management’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$390K Sell
63,703
-28,601
-31% -$187K ﹤0.01% 957
2026
Q1 		$638K Buy
+92,304
New +$712K ﹤0.01% 858
2023
Q3 		– Sell
-220,097
Closed -$1.45M – 1107
2023
Q2 		$1.45M Sell
220,097
-9,989
-4% -$64K 0.01% 729
2023
Q1 		$1.56M Buy
230,086
+89,946
+64% +$632K 0.01% 676
2022
Q4 		$1.04M Buy
140,140
+2,974
+2% +$29K 0.01% 745
2022
Q3 		$1.35M Buy
137,166
+52,321
+62% +$552K 0.01% 594
2022
Q2 		$925K Sell
84,845
-87,477
-51% -$906K 0.01% 676
2022
Q1 		$1.95M Buy
172,322
+42,125
+32% +$554K 0.01% 603
2021
Q4 		$2.04M Buy
130,197
+48,558
+59% +$846K 0.01% 654
2021
Q3 		$1.4M Buy
81,639
+8,428
+12% +$148K 0.01% 733
2021
Q2 		$1.57M Sell
73,211
-27,990
-28% -$501K 0.01% 747
2021
Q1 		$1.52M Buy
101,201
+77,871
+334% +$1.26M 0.01% 685
2020
Q4 		$307K Sell
23,330
-42,064
-64% -$506K ﹤0.01% 803
2020
Q3 		$632K Buy
65,394
+30,373
+87% +$325K 0.01% 657
2020
Q2 		$401K Buy
+35,021
New +$397K 0.01% 762
2020
Q1 		– Sell
-52,858
Closed -$867K – 803
2019
Q4 		$867K Sell
52,858
-86,598
-62% -$1.31M 0.01% 581
2019
Q3 		$1.85M Sell
139,456
-6,028
-4% -$84K 0.03% 408
2019
Q2 		$2.05M Sell
145,484
-19,368
-12% -$308K 0.04% 413
2019
Q1 		$3.03M Buy
+164,852
New +$3.76M 0.05% 220

Other funds holding VNDA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Rafferty Asset Management's VNDA Position: Q2 2026 in Review

Rafferty Asset Management reduced its Vanda Pharmaceuticals (VNDA) stake by 31% in Q2 2026, selling an estimated $187K and leaving 63,703 shares worth $390K. The position accounts for ﹤0.01% of the portfolio, ranked #957.

Rafferty Asset Management first reported a position in VNDA in Q1 2019 and has held it in 19 quarters since. The position peaked at $3.03M in Q1 2019. 173 funds tracked by Wall St. Rank hold VNDA as of Q2 2026.

  • Rafferty Asset Management held 63,703 shares of Vanda Pharmaceuticals worth $390K as of Q2 2026.
  • Rafferty Asset Management sold 28,601 Vanda Pharmaceuticals shares in Q2 2026, an estimated $187K.
  • Vanda Pharmaceuticals made up ﹤0.01% of Rafferty Asset Management's portfolio in Q2 2026, its #957 holding.
  • Rafferty Asset Management first reported a position in Vanda Pharmaceuticals in Q1 2019 and has held it in 19 quarters since.
  • Rafferty Asset Management's Vanda Pharmaceuticals position peaked at $3.03M in Q1 2019.
  • 173 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2026.

Based on Rafferty Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.